Clinical Trials Directory

Trials / Unknown

UnknownNCT05241639

Pentacam Study of the Cornea in RA Patients

Pentacam Study of Rheumatoid Arthritis Activity on Corneal Densitometry, Corneal Curvature, Corneal Thickness and Lens Densitometry.

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To evaluate the effect of rheumatoid arthritis (RA) activity on the corneal densitometry, corneal curvature (CC), central corneal thickness (CCT), and lens densitometry by Pentacam and compared these parameters with those of age-matched healthy control subjects

Detailed description

Case - control observational study on RA patients which divided into 2 groups, each group 120 eyes of 60 patients, group 1 of RA in the remission state and group 2 of RA in the active state. Group 3 of 120 eyes of healthy controls. Pentacam was used to measure corneal densitometry, CC, CCT, and lens densitometry. The cornea was divided into 4 concentric zones (0-2, 2-6, 6-10, and 10-12) and anterior, central, and posterior layers according to the depth

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPentacamPentacam (Oculus GmbH, Wetzlar, Germany) is used to image both the anterior and posterior corneal surfaces, providing a complete pachymetry map. Furthermore, it includes the corneal densitometry program in its software, which detects the amount of backscattered light in different regions of the cornea, providing an objective assessment of corneal transparency, and it is hypothesized that corneal densitometry may be altered in the presence of a systemic inflammatory disease, even in the absence of any corneal haze or scar

Timeline

Start date
2021-06-11
Primary completion
2022-05-13
Completion
2022-05-13
First posted
2022-02-16
Last updated
2022-02-16

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05241639. Inclusion in this directory is not an endorsement.